Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: What are the direct costs of assisted reproductive technology (ART), and how affordable is it for patients in low- and middle-income countries (LMICS)? SUMMARY ANSWER: Direct medical costs paid by patients for infertility treatment are significantly higher than annual average income and GDP per capita, pointing to unaffordability and the risk of catastrophic expenditure for those in need. WHAT IS KNOWN ALREADY: Infertility treatment is largely inaccessible to many people in LMICs. Our analysis shows that no study in LMICs has previously compared ART medical costs across countries in international dollar terms (US$PPP) or correlated the medical costs with economic indicators, financing mechanisms, and policy regulations. Previous systematic reviews on costs have been limited to high-income countries while those in LMICs have only focussed on descriptive analyses of these costs. STUDY DESIGN, SIZE, DURATION: Guided by the preferred reporting items for systematic reviews and meta-analyses (PRISMA), we searched PubMed, Web of Science, Cumulative Index of Nursing and Allied Health Literature, EconLit, PsycINFO, Latin American & Caribbean Health Sciences Literature, and grey literature for studies published in all languages from LMICs between 2001 and 2020. PARTICIPANTS/MATERIALS, SETTING, METHODS: The primary outcome of interest was direct medical costs paid by patients for one ART cycle. To gauge ART affordability, direct medical costs were correlated with the GDP per capita or average income of respective countries. ART regulations and public financing mechanisms were analyzed to provide information on the healthcare contexts in the countries. The quality of included studies was assessed using the Integrated Quality Criteria for Review of Multiple Study designs. MAIN RESULTS AND THE ROLE OF CHANCE: Of the 4062 studies identified, 26 studies from 17 countries met the inclusion criteria. There were wide disparities across countries in the direct medical costs paid by patients for ART ranging from USD2109 to USD18 592. Relative ART costs and GDP per capita showed a negative correlation, with the costs in Africa and South-East Asia being on average up to 200% of the GDP per capita. Lower relative costs in the Americas and the Eastern Mediterranean regions were associated with the presence of ART regulations and government financing mechanisms. LIMITATIONS, REASONS FOR CAUTION: Several included studies were not primarily designed to examine the cost of ART and thus lacked comprehensive details of the costs. However, a sensitivity analysis showed that exclusion of studies with below the minimum quality score did not change the conclusions on the outcome of interest. WIDER IMPLICATIONS OF THE FINDINGS: Governments in LMICs should devise appropriate ART regulatory policies and implement effective mechanisms for public financing of fertility care to improve equity in access. The findings of this review should inform advocacy for ART regulatory frameworks in LMICs and the integration of infertility treatment as an essential service under universal health coverage. STUDY FUNDING/COMPETING INTEREST(S): This work received funding from the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (WHO). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: This review is registered with PROSPERO, CRD42020199312.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due to high cost and/or unaffordability, ART remains out of reach for many, even in resource-rich countries (Dyer et al., 2020; ASRM The Ethics Committee, 2021; Njagi et al., 2023).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Njagi et al., 2023
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Systematic reviews have shown that individuals with infertility problems in LMICs are less likely to have access to any form of ART [31,34], even routine medical care, including psychosocial interventions [35].”
The cited source says what the claim attributes to it.
In the citing paper
“Infertility treatment is disproportionately underutilized in LMICs [30,31] due to the high cost of treatment and the limited financial resources of those affected.”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“While psychosocial interventions are conceptualized in high-income countries and incorporated in the health systems, LMICs are yet to incorporate them in the management of infertility [31].”
From Psychosocial interventions for improving marital intimacy, sexual satisfaction, and quality of life of women and couples with infertility problems in low and middle-income countries: Systematic review protocol (2025) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“In keeping with the study protocol published in the PROSPERO database (CRD42020199312) and elsewhere (Njagi et al., 2020), this study was conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement (Moher et al., 2009).”
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Boivin, J., Bunting, L., Collins, J. A., & Nygren, K. G. (2007) · Human Reproduction · doi:10.1093/humrep/dem046 · Cited by 2,437 · cited 2×
“While reported prevalence estimates vary widely due to different methodologies, global estimates show that between 48.5 and 72.4 million couples have infertility (Boivin et al., 2007; Mascarenhas et al., 2012).”
InfluentialDevelopment of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)
Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011458 · Cited by 2,376 · cited 1×
“For cross-sectional studies, we applied the criteria for non-controlled studies complemented by the quality assessment tool for observational and cross-sectional studies provided by the National Institutes of Health (Downes et al., 2016; Ma et al., 2020).”
MethodMascarenhas, M. N., Flaxman, S. R., Boerma, T., Vanderpoel, S., & Stevens, G. A. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001356 · Cited by 2,312 · cited 4×
“However, infertility is itself a widely prevalent cause of significant health burden for millions of people (Makuch et al., 2010; Mascarenhas et al., 2012; Cox et al., 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al.”
BackgroundInfluentialInternational Statistical Classification of Diseases and Related Health Problems 10th Revision
(2013) · A Companion to the Classification of Mental Disorders · doi:10.1093/med/9780199669493.005.0005 · Cited by 2,059
Inhorn, M. C., & Patrizio, P. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv016 · Cited by 1,926 · cited 2×
“intervention throughout the world (Bitler and Schmidt, 2012; Inhorn and Patrizio, 2015; Sharma et al., 2018).”
BackgroundMa, L.-L., Wang, Y.-Y., Yang, Z.-H., Huang, D., Weng, H., & Zeng, X.-T. (2020) · Military Medical Research · doi:10.1186/s40779-020-00238-8 · Cited by 1,648
Starrs, A. M., Ezeh, A. C., Barker, G., Basu, A., Bertrand, J. T., Blum, R., Coll-Seck, A. M., Grover, A., Laski, L., Roa, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30293-9 · Cited by 1,598 · cited 2×
“, 2022) that should be the addressed alongside other health needs to achieve universal health coverage (Starrs et al., 2018).”
Background
Research works printed but not linked: 6
- Boarini R, Johansson Å, d’Ercole MM. Alternative measures of well-being OECD Social, Employment and Migration Working Papers Series, No 33. Paris: Organisation for Economic Co-operation and Development (OECD), 2006. Available from: https://www.oecd-ilibrary.org/economics/alternative-measures-of-well-being_832614168015 (21 October 2021, date last accessed).
- International Federation of Fertility Societies’ Surveillance (IFFS). Global trends in reproductive policy and practice. Glob Reprod Health 2019; 4: e29.
- Inhorn MC, Gürtin ZB. Infertility and assisted reproduction in the muslim middle east: social, religious, and resource considerations. Facts Views Vis ObGyn 2012; 6: 24– 29.
- Khalifa DS. Reviewing infertility care in Sudan; socio-cultural, policy and ethical barriers. Facts Views Vis ObGyn 2012;Monograph: 53– 58.
- Sangamithra DA. An economic analysis of socio-economic variables and treatment cost of infertility. Shanlax Int J Econ 2015; 3: 5– 10.
- Tangwa GB. ART and African sociocultural practices: worldview, belief and value systems with particular reference to francophone Africa. Vayena E Curr Pract Controv Assist Reprod 2002; 5: 55– 59.
Cited by
Items 201–276 of 276
Tian, Y., Lyu, L., Yang, H., Yang, Y., Li, Z., Zeng, Y.-Y., Liu, H.-Z., Yang, L., & Zhang, X. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119503
Sanagoudar, S., Chandra, V., Nigam, S., Gahalan, A., Punhani, R., Pandey, N., Zaidi, S., Panday, J., Bhoi, N. R., Mistari, W., et al. (2025) · Cureus · doi:10.7759/cureus.98622
Afferri, A., Dierickx, S., Allen, H., Bittaye, M., Marena, M., Pacey, A. A., & Balen, J. (2024) · Figshare · doi:10.6084/m9.figshare.26689385
Afferri, A., Dierickx, S., Allen, H., Bittaye, M., Marena, M., Pacey, A. A., & Balen, J. (2024) · Figshare · doi:10.6084/m9.figshare.25347037
Afferri, A., Dierickx, S., Allen, H., Bittaye, M., Marena, M., Pacey, A. A., & Balen, J. (2024) · Figshare · doi:10.6084/m9.figshare.25347262
Xu, Y., Jia, Y., Li, Q., Jiang, H., Xiong, Y., Liang, W., Liu, X., Huang, Y., Zou, K., Sun, X., et al. (2025) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.70100 · Cited by 3
“Infertility is a major factor affecting fertility and human health, and has become a worldwide public health issues, affecting 17.5% adults globally (1/6 of global population) [ 2–4 ].”
InfluentialLi, Q., Su, X., xia, Z., Ji, D., Dong, R., Yin, T., Yue, X., Zhang, D., Cao, Y., 纪冬梅, et al. (2025) · Environmental Research · doi:10.1016/j.envres.2025.123617
Abdelkarim, M., Ghannem, N., Berjeb, K. K., Chtourou, S., Debbabi, L., Fadhlaoui, A., Mefteh, M. B., Zhioua, F., Braham, M., & Chakroun, N. F. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020403 · Cited by 1
“Male infertility accounts for approximately 40–50 percent of infertility cases globally [1].”
Wu, S., Miao, D., Chen, J., & Ge, W. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116242
Li, X., Ye, Y., Li, N., Wang, C., Chen, Y., Xu, Z., & Zheng, X. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-026-03805-5
Adu, I. K., Owusu, V. B., Amoako, E. K., Attoh, G. N. A., Asiedu, E. K., Banyeh, M., Alhassan, I. Z., & Amidu, N. (2026) · American Journal of Men s Health · doi:10.1177/15579883261430887 · Cited by 1
“This is particularly important in low-and middle-income settings where ART is often costly and largely self-funded (Njagi et al., 2023; Whittaker et al., 2024).”
Pathak, B. G., Mburu, G., Habib, N., Kabra, R., Kiarie, J. N., Chowdhury, R., Dhabhai, N., & Mazumder, S. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1772807 · Cited by 1
“High costs of infertility diagnosis and treatment further detercare-seeking, particularly where services are not publicly financed or subsidized (22–24).”
Self-citationImproving access to fertility treatment in Asia Pacific: consensus from an expert forum
Abat, M. A. G., Armstrong, H., Chen, M., Fatemi, H. M., Hung, H. S., Nakagawa, K., Pannu, N. S., Petrova, A., Pistollato, M., Pruksananonda, K., et al. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1738726 · Cited by 2
“Evidence from South-East Asia indicates that the direct out-of-pocket cost of a single ART cycle ranges from approximately US $1,000 to US$5,596, levels that may be prohibitive for large segments of the population (20).”
InfluentialRoemer-Ślimak, R., Zimny-Zając, A., Kłoda, K., Babicki, M., Makuch, S., Jankowska-Polańska, B., Tański, W., Mastalerz-Migas, A., Mazur, G., & Agrawal, S. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115088
Alemu, S. S., Aboabe, E., Zemedkun, K., Gejo, N. G., Hajure, M., Demsash, A. W., Fekadu, G., Dube, G. N., Daba, Y., Wedajo, L. F., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-46059-y · Cited by 1
Cryopreservation of Spermatozoa
Garrido, N., Papaharitou, S., Rosas, I. M., Japari, A., & Arafa, M. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009476072.009
Shi, H., Chen, C., Ran, Z., Liao, J., Wu, Z., Wang, X., Zhao, Y., Ke, W., Tan, B., Liu, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.75223 · Cited by 2
Lê, M. T., Nguyen, T. V., Vo, C. V., Nguyen, B. H., & Nguyen, Q. H. V. (2026) · Reproductive Biology · doi:10.1016/j.repbio.2026.101216
The future of personalized fertility treatment with nanomedicine
Acharyya, S., Sahu, S., Patra, P. K., Pradhan, R., Dolui, R., & Kumar, H. K. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41561-6.00001-7
Fertility restoration: Nanotechnology and stem cell synergies
Jahnavi, P., Pushkalai, S. P., Maddi, R., Arul, V., Patwekar, V., & Krishnan, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41561-6.00012-1
Kepkep, B., Botos, M. S., Yazici, İ., Frivaldszky, L., Rancz, A., Hegyi, P., Ács, N., Melczer, Z., Szentes, B., & Sipos, M. (2026) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-026-01546-9 · Cited by 1
“The cost of ART depends on the protocol and medications used and varies worldwide, ranging from $2,109 to $18,592 [5].”
Benbella, A., Zaidouni, A., Elomrani, S., Mburu, G., Hardizi, H., Yahyane, A., Hachri, H., Gholbzouri, K., Kiarie, J., & Bezad, R. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005318 · Cited by 1
“…and social values [36]) have been shown to influence the extent to which populations are motivated to engage with and seek help from infertility services, while at the same time, contributing to stigmatization, secrecy [37] and economics hardships [38] among couples with infertility who seek help.”
Self-citationTHE VAGINAL AND ENDOMETRIAL MICROBIOME IN ASSISTED REPRODUCTIVE TECHNOLOGY (ART)
Krajewska, A., Kowalik, A., Korzeniewska, A. M., Dębczak, J. A., Łuczak, K., Tłustochowicz, K., Korba, M., Malicka, N., & Polkowska, W. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.5262
Bannour, I., Guerbej, E., Romdhani, M., Bannour, R., Abbassi, H., Dali, S., Chahed, S., & Boughizane, S. (2026) · Cureus · doi:10.7759/cureus.107689 · Cited by 1
“Assisted reproductive technology (ART), despite being a major biomedical advancement, remains inaccessible to a large proportion of infertile couples due to high costs, prolonged treatment duration, and substantial emotional burden, with no guarantee of success [6,7].”
Didžiokaitė, G., Kuznecovaitė, A., Žvirblė, M., Survila, Ž., Pašukonienė, V., & Kvedarienė, V. (2026) · Antioxidants · doi:10.3390/antiox15050611 · Cited by 1
“It is estimated to affect 12.6% to 17.5% of couples globally [2].”
InfluentialNdlovu, B. M., & Chipangura, B. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23050663
“In LMICs, the implementation of digital health technologies occurs within in-frastructural and economic environments that differ substantially from high-income contexts [21–23 ,40,41].”
Aliasghari, F., Hamdi, K., Mohammadzadeh, Z., Abdolalipour, S., & Mirghafourvand, M. (2026) · Reproductive Health · doi:10.1186/s12978-026-02362-5
“Uncertainty regarding diagnosis and treatment outcomes, repeated medical interventions, and treatment failure further intensify emotional distress, leading to feelings of shame, hope-lessness, and loss of control [2, 8, 9].”
Storck-Thy, C., Dessing, L., Jensen, B. H., Oxlund-Mariegaard, B. S., Krogfelt, K. A., & Jønsson, R. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-118867
Stage-specific expression dynamics of ESRRG orchestrate zygotic genome activation in mouse embryos
Sun, J., Liao, S., Lin, Z., Lian, X., Xu, W., Liu, Y., Wang, X., Lin, Z., Zhang, D., & Wang, S. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112639
EmbryoCST: A Stage-Aware ResNet with Layered CNN-3D Swin Transformer for Embryo Stage Classification
(39052), Y. Z., Li, X., Cai, Z., Pei, J., (1395235), X. Y., & Wu, J. (2026) · Lecture notes in computer science · doi:10.1007/978-981-92-1462-4_10
Ata, B., Al‐Rumaih, H., Matar, H., Alhudhud, M., Dik, M., Dhainy, M., Daher, R., Sherif, S. S., & Nakad, T. I. (2026) · Middle East Fertility Society Journal · doi:10.1186/s43043-026-00341-1
“…have demonstrated substantial global variation in ART costs and financing models, with public funding mechanisms in some high-income settings partially mitigating the economic burden of treatment, whereas out-of-pocket expenditure remains a major barrier in resource-constrained settings [13, 14].”
Mehriban, N., Shimul, M. M. H., Mondol, P., Salam, S., Hossain, R., Rokon-Uz-Zaman, M., & Khandker, S. (2026) · Mental Illness · doi:10.1155/mij/4433484
Alverde, M. J. B., Yu, S., Pontón, D. P., Harari, D. N. B., & Lasman, J. E. T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1741198
“In addition, methodological concerns such as retrospective design and unaccounted confounders continue to limit the strength of existing evidence (2, 9).”
Fadare, R. I., Ogbujiagba, V. C., Bello, C. B., Ogbeye, G. B., & Fadare, O. E. (2026) · Research in Health Services & Regions · doi:10.1007/s43999-026-00093-5
Overlapping and distinct fatty acid dysregulation in infertility and recurrent spontaneous abortion
Wei, S., Li, Y., Luo, P., Yang, X., & Zheng, P.-S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1866902
Zhang, C., Ramaiya, A., Mandeville, J., Godongwana, M., Babbar, K., & Gupta, J. (2026) · Global Public Health · doi:10.1080/17441692.2026.2683738
Stanford, J. B., Harris, E., Najmabadi, S., & Smith, K. R. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1856175
Hu, X., 陈智英, & Luo, H. (2026) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-026-03939-6
“…several limitations: conventional sperm and embryo assessment methods heavily rely on the subjective expertise of embryologists; clinical decision-making lacks precise predictive tools; and patients often endure anxiety, uncertainty, and psychological stress throughout the treatment process [2].”
Садраддинович, И. Б., Николаевна, Л. О., Moroz, T. A., Владимирович, М. Д., Ушакова, С., Pridanova, I. E., & Brigida, A. (2026) · Reproduction and Breeding · doi:10.1016/j.repbre.2026.05.004
von Wiegen, N., Schömbs, L., Haack, A. M., Pan, Y., Tan, K., Schmitz, C., Jahnen‐Dechent, W., Clement, A. M., Floehr, J., Behl, C., et al. (2026) · Molecular Human Reproduction · doi:10.1093/molehr/gaag041
Low-cost in-vitro fertilisation as reproductive justice: reframing infertility care in global health
Ombelet, W., Blerkom, J. V., & Nargund, G. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(26)00075-0
Ayoade-Suleiman, K. B., Olatunji, O. E., & Etukudo, E. M. (2026) · Phytomedicine Plus · doi:10.1016/j.phyplu.2026.101025
Horta, F., Sakkas, D., Handley, S., Xiong, Y., Mihalas, B. P., Deans, R., Hart, R. J., Gilchrist, R. B., & Goldys, E. M. (2026) · Human Reproduction · doi:10.1093/humrep/deag114
“Infertility is a global health concern that affects one in six people globally (Njagi et al. , 2023; World Health Organization, 2025), and the rates of infertility across the world are inexorably rising (Aitken, 2022).”
Qiang, R., Xu, Z., Wang, Y., Gu, Y., Liu, Y., He, Q., Zhu, Y. L., & Pan, X. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1891276
“Infertility is a disease de fi ned as the failure to achieve a clinical pregnancy, representing a major global health challenge and a signi fi cant contributor to substantial economic burden (1, 25, 26).”
Kyei, F., Napo, C., Nabawo, C., Asante, E. O., Nyarko, B., Adu, I. K., Aidoo, C. O., Essien, V., Barnie, P. A., Ansah, E. O., et al. (2026) · Reproductive Health · doi:10.1186/s12978-026-02410-0
“In African countries where the cost of a single ART cycle exceeds the average annual household income, the unregulated introduction of high-cost molecular technologies risks creating two-tier fertility systems that will only be the privilege of urban and higher-income populations [3].”
InfluentialMoore, D., & Flores-Carter, K. (2026) · Community Health Equity Research & Policy · doi:10.1177/2752535x261467906
Polatlı, H., & Tandoğan, Ö. (2026) · Disiplinlerarası Yenilik Araştırmaları Dergisi · doi:10.56723/dyad.1861431
Ochando, I., Gabucio, L. M. C., Urbano, A., Andrés, M., Marco-Lledó, J., Zorrilla-Muñoz, V., Hernández‐Borges, J., Madrigal-Verdú, P., Campos, J. G., Morales-Delgado, N., et al. (2026) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2026.105122
Messina, A., Motarajji, S. E., Chimenti, C., Valloreo, F., Masturzo, B., & Leo, L. (2026) · Women · doi:10.3390/women6030052
“IUI requires less intensive ovarian stimulation, does not involve oocyte retrieval or embryo culture, and can usually be performed in an outpatient setting without the need for advanced laboratory procedures [33,34].”
InfluentialVikani, A., Patil, P., Sharma, D., Sachin, O., Soman, B., Bagepally, B. S., Tanwar, R., Suri, V., Radha, V., Anitha, M., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-112480
Cifuentes, E.-A., Lapalus, J., Damase‐Michel, C., & Bénevent, J. (2026) · F&S Reviews · doi:10.1016/j.xfnr.2026.100118
İnfertil Kadınlarda Stres ile Yaşam Kalitesi Arasındaki İlişki: Kesitsel Araştırma
Can, A. A., & Emül, T. G. (2026) · Bandırma Onyedi Eylül Üniversitesi Sağlık Bilimleri ve Araştırmaları Dergisi · doi:10.46413/boneyusbad.1724810
Jiang, F., Liao, Z., Chen, Y., Gu, Q., Luo, G., Xu, Q., Wang, J., & Wang, D. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1923237
“Globally, this affects approximately 48.5 to 72.4 million couples (3), representing nearly one in seven couples of reproductive age (4).”
InfluentialVachlova, O. S., & Roslaya, N. A. (2026) · Medicine and health care organization · doi:10.56871/mhco.2026.36.13.005
Wang, L., Qiao, Q., You, H.-N., Zheng, Y.-B., Wu, X., Wen-jie, Y., Liu, Z., Song, W.-J., Zhang, L.-H., Hu, J.-R., et al. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116359
Prasad, M., Arora, P. R., Patki, A. S., Kumar, C., Das, G., Kapoor, G., Jevalikar, G., Patil, M., Kalra, M., Khanna, N. R., et al. (2026) · Indian Journal of Medical and Paediatric Oncology · doi:10.1055/s-0046-1827017
“37 This when coupled with the absence of insurance cover for such treat-ment, points to unaffordability and the risk of catastrophic expenditure for those in need.”
Wang, X., Yan, H., Li, C., Feng, Y., Gao, S., Zhang, J., Zhao, H., Zhang, J., Guo, C., & Zhao, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1914158 · Cited by 1
Pilarczyk, R., Zimny-Zając, A., Dróżdż, M., Jankowska-Polańska, B., Mazur, G., & Agrawal, S. (2026) · Reproduction and Fertility · doi:10.1530/raf-26-0056
Kushtekova, A. T., Nogayeva, M. G., Yermukhanova, L. S., Lokshin, V. N., Nurbakyt, A. N., Tazhiyeva, A. Y., Musina, A. A., Mussakhanova, A., & Afshar, A. (2026) · Healthcare · doi:10.3390/healthcare14182941
“This deserves attention because out-of-pocket ART expenditures can be substantial and financially burdensome in low-and middle-income settings [35].”
Cosby, R. L., Brolinson, M. G., Poch, A. M., Evans, M. B., Watkins‐Chow, D. E., Young, B., Ralls, S., Gomez‐Lobo, V., Aston, K. I., Conrad, D. F., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.10.750150
Phytochemicals and Nanotechnology in the Management of Infertility
Patani, B., Jackson, C., & Melifonwu, M. (2026) · American Journal of Nano Research and Applications · doi:10.11648/j.nano.20261403.11
Ganchuluun, T.-A., Hsu, W.-T., & Hung, S. (2026) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2026.102765
Cretu, A.-M., Oprea, O. G., Săvucă, A., Ciobîcă, A., & Doroftei, B. (2026) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2026.3.07
Henkel, R., Arafa, M. M., Majzoub, A. A., Elbardisi, H., & Das, M. (2026) · Frontiers in Urology · doi:10.3389/fruro.2026.1926391
Chang, H., Feng, J., Lei, L.-X., Lin, X., Chen, M., Gao, Z., Wang, J., & Li, H. (2026) · American Journal of Men s Health · doi:10.1177/15579883261492747
Didiso, W. M., Ayalewu, B. B., & Yirga, S. A. (2026) · Discover Global Society · doi:10.1007/s44282-026-00620-2
“In additionally the most effective way to assess how well an organization is performing, according to this research, is by using a combined approach that looks at both financial and non-financial measures [58].”
Impact of Reiki on infertile women in Assisted Reproduction: a randomized clinical trial
Borges, M. L., Margatho, A. S., dos Reis, R. M., Perdoná, G. C., de Araújo, M. C. P. M., Guimarães, C. S., & Panobianco, M. S. (2026) · Acta Paulista de Enfermagem · doi:10.37689/acta-ape/2026ao1752i
Badejogbin, O. C., Oludare, G. O., & Iranloye, B. O. (2026) · Endocrines · doi:10.3390/endocrines7040058
Kamath, R., Rodrigues, G., Singh, S., Akthar, N., Shenoy, R. R., & Kini, S. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1922605
Afferri, A., Apps, J., Crowther, M., Mburu, G., Kiarie, J. N., & Balen, J. (2026) · Human Reproduction Update · doi:10.1093/humupd/dmag031
Self-citationSurrogacy in Ukraine: Legal Nature, Boundaries of Lawful Practice, and Challenges under Martial Law
BONDARENKO-ZELINSKA, N. L., & ЗЕЛІНСЬКИЙ, А. (2026) · University Scientific Notes · doi:10.37491/unz.112.10
Endara-Mina, J., Bermúdez-Gavilanes, J., Salazar, F.-R., Manzano-Gallegos, L. A., Figueroa-Andrade, J. M., Ortega-Parraga, D. N., González-Naranjo, D. E., Maldonado-Montalvan, F., Reytor-González, C., & Simancas‐Racines, D. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1974930
Bouchard, T. P., Yong, P. J., & Doyle–Baker, P. K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1947016
Hatoum, S., Amiri, M., Makwe, C. C., Olamijulo, J. A., & Azziz, R. (2026) · Gynecological Endocrinology · doi:10.1080/09513590.2026.2750762
Metadata
- Authors
- Njagi, P., Groot, W., Arsenijevic, J., Dyer, S., Mburu, G., & Kiarie, J.
- Affiliations
- United Nations University – Maastricht Economic and Social Research Institute on Innovation and Technology (NL)
- Utrecht University (NL)
- University of Cape Town (ZA)
- World Health Organization (CH)
- Corresponding author
- Njagi, Purity
- Venue
- Human Reproduction Open
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-01-01
- Volume
- 2023
- Issue
- 2
- Pages
- hoad007-hoad007
- ISSN
- 2399-3529 (ISSN-L)
- PMC
- PMC10029849
- OpenAlex
- W4322730891
- Cited by
- 277
- References
- 65
- Citations by year
- 2026: 86 · 2025: 106 · 2024: 71 · 2023: 14
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Human Reproduction Open (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, cc-by)
- Funders
- UNDP-UNFPA-UNICEF-WHO-World Bank
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
- Keywords
- assisted reproduction, infertility treatment, direct medical costs, patient affordability, low- and middle-income countries, GDP per capita, ART regulation, access to fertility care, health policy implications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.